Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain

Abstract

Get full access to this article

View all access options for this article.

References

Zech FJD , Lehmann KA , Grond S . A new treatment option for chronic cancer pain. Eur J Pall Care 1994; 1: 26–30.

Fine PG , Streisand JB . A review of oral transmucosal fentanyl citrate: potent, rapid and noninvasive opioid analgesia. J Pall Med 1998; 1: 55–63.

Streisand JB , Varvel JR , Stanski DR et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991; 75: 223–229.

Worsley MH , MacLeod AD , Brodie MJ , Asbury AJ , Clark C . Inhaled fentanyl as a method of analgesia. Anaesthesia 1990; 45: 449–451.

Striebel HW , Koenigs D , Krämer J . Post-operative pain management by intranasal demand-adapted fentanyl titration. Anesthesiology 1992 77: 281–285.

Ahmedzai S , Davis C . Nebulised drugs in palliative care. Thorax 1997; 52 (suppl 2): S75–S77.

Portenoy RK , Hagen NA . Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273–281.

Banning A , Sjøgren, Henriksen H . Treatment outcome in a multidisciplinary cancer pain clinic. Pain 1991; 47: 129–134.

Fine PG , Busch MA . Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage 1998; 16: 179–183.

10.

Portenoy RK , Payne R , Coluzzi P et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 1999; 79: 303–312.

11.

Clay MM , Clarke SW . Wastage of drug from nebulisers: a review. J R Soc Med 1987; 80: 38–39.

12.

Hardy JG , Lee SW , Wilson CG . Intranasal drug delivery by spray and drops. J Pharm Pharmacol 1985; 37: 294–297.